US 2026/0297147 A1 · Keratin YK93-2, and Preparation Method Therefor, Pharmaceutical Composition Thereof and Use Thereof

Abstract

The present invention belongs to the field of biopharmaceuticals. Provided are a keratin YK93-2, a nucleic acid molecule encoding the same, an expression vector including the nucleic acid molecule, a host cell including the expression vector or the genome integrated with the nucleic acid molecule, a preparation method therefor and a pharmaceutical composition thereof. Further provided is the use of the above-mentioned product, such as keratin YK93-2 in the preparation of a drug for treating lung cancer, lymphoma, breast cancer, melanoma, uterine fibroid, prostatic hyperplasia etc.

Claims16

Dependent claims

A keratin YK93-2, wherein the amino acid sequence of the keratin YK93-2 is:

(1) the amino acid sequence set forth in SEQ ID NO.1 in the sequence listing;
or
(2) an amino acid sequence formed by substitution, deletion or addition of 1-35 amino acids in the amino acid sequence set forth in SEQ ID NO.1 in the sequence listing that basically maintains the same biological function.

Dependencies are inferred from the claim text.

Keratin YK93-2, and Preparation Method Therefor, Pharmaceutical Composition Thereof and Use Thereof

Life of this patent

Keratin YK93-2, and Preparation Method Therefor, Pharmaceutical Composition Thereof and Use Thereof

Life of this patent

Abstract

Claims16